Lyell Immunopharma (LYEL) Accumulated Depreciation & Amortization (2020 - 2024)
Historic Accumulated Depreciation & Amortization for Lyell Immunopharma (LYEL) over the last 6 years, with Q4 2024 value amounting to $19.6 million.
- Lyell Immunopharma's Accumulated Depreciation & Amortization fell 305.68% to $19.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $19.6 million, marking a year-over-year decrease of 305.68%. This contributed to the annual value of $19.6 million for FY2024, which is 305.68% down from last year.
- Latest data reveals that Lyell Immunopharma reported Accumulated Depreciation & Amortization of $19.6 million as of Q4 2024, which was down 305.68% from $20.2 million recorded in Q4 2023.
- Over the past 5 years, Lyell Immunopharma's Accumulated Depreciation & Amortization peaked at $20.2 million during Q4 2023, and registered a low of $4.3 million during Q4 2020.
- For the 5-year period, Lyell Immunopharma's Accumulated Depreciation & Amortization averaged around $15.2 million, with its median value being $18.0 million (2022).
- In the last 5 years, Lyell Immunopharma's Accumulated Depreciation & Amortization skyrocketed by 24187.9% in 2020 and then plummeted by 305.68% in 2024.
- Over the past 5 years, Lyell Immunopharma's Accumulated Depreciation & Amortization (Quarter) stood at $4.3 million in 2020, then skyrocketed by 217.28% to $13.6 million in 2021, then soared by 32.27% to $18.0 million in 2022, then grew by 12.38% to $20.2 million in 2023, then decreased by 3.06% to $19.6 million in 2024.
- Its last three reported values are $19.6 million in Q4 2024, $20.2 million for Q4 2023, and $18.0 million during Q4 2022.